| 9550774 |
Dihydropyrido pyrimidine compounds as autotaxin inhibitors |
Thomas John Bleisch, Robert Anthony Doti, Lance Allen Pfeifer |
2017-01-24 |
$414,114,000 |
| 9394317 |
Imidazo pyridine compounds |
Spencer Jones, Lance Allen Pfeifer |
2016-07-19 |
$258,194,000 |
| 8969555 |
Bicyclic pyrimidine compounds |
Thomas Beauchamp, Yen Dao, Spencer Jones, Lance Allen Pfeifer |
2015-03-03 |
$268,794,000 |
| 8648200 |
Imidazole derivatives useful for the treatment of arthritis |
Norman Earle Hughes, Timothy Andrew Woods |
2014-02-11 |
$66,894,000 |
| 8093302 |
Substituted tetralins as selective estrogen receptor-β agonists |
Elizabeth Marie Thomas, Julian Stanley Kroin |
2012-01-10 |
$65,439,000 |
| 7842822 |
Substituted benzopyrans as selective estrogen receptor-beta agonists |
Gregory Lee Durst, Timothy Ivo Richardson |
2010-11-30 |
$152,437,000 |
| 7585985 |
Substituted benzopyrans as selective estrogen receptor-beta agonists |
Lance Allen Pfeifer, Timothy Ivo Richardson |
2009-09-08 |
$83,913,000 |
| 7442812 |
Substituted benzopyrans as selective estrogen receptor-beta agonists |
Gregory Lee Durst, Timothy Ivo Richardson |
2008-10-28 |
$187,380,000 |
| 7354951 |
Substituted benzopyrans as selective estrogen receptor-beta agonists |
Timothy Ivo Richardson |
2008-04-08 |
$129,752,000 |
| 7279499 |
Substituted benzopyrans as selective estrogen receptor-beta agonists |
Gregory Lee Durst, Lance Allen Pfeifer, Timothy Ivo Richardson |
2007-10-09 |
$177,791,000 |
| 7217734 |
Substituted benzopyrans as selective estrogen receptor-beta agonists |
Jeffrey A. Dodge, Venkatesh Krishnan, Charles Willis Lugar, III, Blake L. Neubauer, Lance Allen Pfeifer +1 more |
2007-05-15 |
$90,905,000 |
| 6998415 |
Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
Roland S. Rogers, James A. Sikorski, Balekudru Devadas, Matthew J. Graneto, Jeffery Carter +3 more |
2006-02-14 |
$23,430,000 |
| 6875785 |
Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
John J. Talley, James A. Sikorski, Matthew J. Graneto, Jeffery Carter, Balekudru Devadas +1 more |
2005-04-05 |
|
| 6753344 |
Thiophene substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
John J. Talley, James A. Sikorski, Matthew J. Graneto, Jeffery Carter, Balekudru Devadas +1 more |
2004-06-22 |
|
| 6743794 |
Methods and compounds for inhibiting MRP1 |
Rosanne Bonjouklian, Jeffrey Daniel Cohen, Joseph Michael Gruber, Douglas Webb Johnson, Louis Nickolaus Jungheim +14 more |
2004-06-01 |
$118,923,000 |
| 6696477 |
Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
John J. Talley, James A. Sikorski, Matthew J. Graneto, Jeffery Carter, Balekudru Devadas |
2004-02-24 |
|
| 6680311 |
Cryptophycin compounds |
Rima Al-Awar, William J. Ehlhardt, Subbaraju V Gottumukkala, Michael John Martinelli, Eric David Moher +7 more |
2004-01-20 |
$458,225,000 |
| 6677364 |
Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
John J. Talley, James A. Sikorski, Balekudru Devadas, Matthew J. Graneto, Jeffery Carter +3 more |
2004-01-13 |
|
| 6515014 |
Thiophene substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
John J. Talley, James A. Sikorski, Matthew J. Graneto, Jeffrey S Carter, Balekudru Devadas +1 more |
2003-02-04 |
|
| 6512121 |
Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
John J. Talley, James A. Sikorski, Matthew J. Graneto, Jeffrey S Carter, Balekudru Devadas +1 more |
2003-01-28 |
|
| 6432999 |
Pyrazole substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
John J. Talley, James A. Sikorski, Matthew J. Graneto, Jeffrey S Carter, Balekudru Devadas +1 more |
2002-08-13 |
$250,692,000 |
| 6417193 |
Methods for inhibiting MRP1 |
Joseph Michael Gruber |
2002-07-09 |
$83,855,000 |
| 6369070 |
Methods for inhibiting mrp1 |
Joseph Michael Gruber, Julian Stanley Kroin |
2002-04-09 |
$236,447,000 |
| 6221876 |
Methods for inhibiting MRP1 |
Joseph Michael Gruber, Sean Patrick Hollinshead, Joseph Wilson |
2001-04-24 |
$234,679,000 |
| 6180633 |
Drug resistance and multidrug resistance modulators |
Julian Stanley Kroin |
2001-01-30 |
$201,916,000 |
